Promisia Healthcare Limited logo

SPH Notice

Substantial Holder Notice28 January 2021PHLHealthcare

12564443_1
Disclosure of movement of 1% or more in substantial holding

or change in nature of relevant interest, or both

Sections 277 and 278, Financial Markets Conduct Act 2013

To NZX Limited

and

To Promisia Integrative Limited

Relevant event being disclosed: Movement of 1% or more in substantial holding

Date of relevant event: 28 January 2021

Date this disclosure made: 28 January 2021

Date last disclosure made: 3 November 2020

Substantial product holder(s) giving disclosure

Full name(s): Thomas David Brankin and Michael John Kirwin Lay as trustees of the

Brankin Family Interest Trust

Summary of substantial holding

Class of quoted voting products: Ordinary Shares

Summary for Thomas David Brankin and Michael John Kirwin Lay as trustees of the

Brankin Family Interest Trust

For this disclosure,—

(a) total number held in class: 9,112,099,278

(b) total in class: 16,901,797,451

(c) total percentage held in class: 53.912%

For last disclosure,—

(a) total number held in class: 9,103,804,201

(b) total in class: 16,151,797,451

(c) total percentage held in class: 56.364%

Details of transactions and events giving rise to relevant event

Details of the transactions or other events requiring disclosure:

Acquisition of 8,295,068 ordinary shares in Promisia Integrative Limited from Wells

Investments Limited to Thomas David Brankin and Michael John Kirwin Lay as trustees of

the Brankin Family Interest Trust on 11 November 2020 at $0.009 per share pursuant to a

put option deed dated 1 October 2018.



12564443_1

Details after relevant event

Details for Thomas David Brankin and Michael John Kirwin Lay as trustees of the Brankin

Family Interest Trust

Nature of relevant interest(s): Registered holder of shares in Promisia Integrative Limited

as trustee of the Brankin Family Interest Trust.

For that relevant interest,—

(a) number held in class: 9,112,099,278

(b) percentage held in class: 53.912%

(c) current registered holder(s): Wells Investment Limited

(d) registered holder(s) once transfers are registered: Thomas David Brankin and

Michael John Kirwin Lay as trustees of the Brankin Family Interest Trust

Additional information

Address(es) of substantial product holder(s): 105 Messenger Terrace, Oakura, New

Zealand

Contact details: Stephen Underwood, +64 27 499 3387

Nature of connection between substantial product holders: Thomas David Brankin and

Michael John Kirwin Lay are trustees of the Brankin Family Interest Trust.

Name of any other person believed to have given, or believed to be required to give, a

disclosure under the Financial Markets Conduct Act 2013 in relation to the financial

products to which this disclosure relates: N/A

Disclosure has effect for purposes of directors’ and senior managers’ disclosure

Thomas David Brankin is also a director of Promisia Integrative Limited. This disclosure

also constitutes disclosure for the purposes of the directors’ and senior managers’

disclosure obligations.

Certification

I, Thomas David Brankin, certify that, to the best of my knowledge and belief, the

information contained in this disclosure is correct and that I am duly authorised to make

this disclosure by all persons for whom it is made.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.